Sarc

Ann Arbor, MI

UEI
G9GQJWPKUZP9
CAGE
36NB6
Primary NAICS
Not on record
SAM.gov registration
Active through

Company facts

Self-certified in SAM.gov
  • Non-Profit Organization
Entity structure
Corporate Entity (Tax Exempt)
SAM.gov registration date
Physical address
24 Frank Lloyd Wright Dr, Ann Arbor, MI 48105, USA
Website
sarctrials.org
Founded
2003
Employees
1-10
Estimated annual revenue
$0-$1M
Industry
  1. Financials
  2. Diversified Financials
  3. Capital Markets
  4. Fundraising
SIC code
83 Social Services
Profiles

Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .

Grant awards

Award Agency Obligated Awarded
A phase 2 trial of NAB-sirolimus in patients with progressing or symptomatic epithelioid hemangioendothelioma HT94252510418 Defense Health Agency $3,238,909
A collaborative approach to analyze and target the EWS-FLI1 transcription factor in patients with ewing sarcoma U01CA236220 National Cancer Institute (NIH) $3,751,697
Accelerated clinical development of rational therapies for malignant peripheral... W81XWH1710695 Defense Health Agency $975,778
Phase i/II trial of an HSP90 inhibitor in combination with an mtor inhibitor for patients with refractory malignant… W81XWH1310072 Department of Defense $1,124,998
Sarc sarcoma spore U54CA168512 National Cancer Institute (NIH) $11,007,191

Latest 5 listed here. See the rest on GovTribe.

Quick answers

Is Sarc registered in SAM.gov?

Yes. Sarc's SAM.gov registration is active through August 3, 2027.

What is Sarc's most recent federal award?

Sarc's most recent federal grant award is A phase 2 trial of NAB-sirolimus in patients with progressing or symptomatic epithelioid hemangioendothelioma (HT94252510418), from Defense Health Agency, on August 1, 2025.

On GovTribe

See Sarc's full federal record

  • Federal grant awards
  • Funding analysis by agency, NAICS and set-aside
  • Similar vendors
Try for free Login